This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Diabetes: Many Faces of the Disease - VIRTUAL CONTENT AVAILABLE ON DEMAND
joint with Obesity: From Cell to Patient - VIRTUAL CONTENT AVAILABLE ON DEMAND
Organizer(s): Lori Sussel, Juleen R. Zierath and Laura C. Alonso
Date: February 01 - 03, 2021
Location: Virtual at your computer. Recorded presentation content is available On Demand.
Sponsored by AstraZeneca and Novo Nordisk A/S
For important information on the coronavirus, please click here
Summary of Meeting:
Diabetes continues to be a growing health problem throughout the world; the incidence of both type 1 diabetes (T1D) or type 2 diabetes (T2D) has steadily been rising. However, with the advent of novel technologies, high throughput sequencing, and clinical studies involving diverse human populations, there also has been a growing appreciation for the existence of sub-classifications of both T1D and T2D based on genetics and environmental influences. Understanding and characterizing the different diseases is critical to develop more effective personalized therapies. Therefore, the goal of this conference is to highlight traditional and novel aspects of diabetes research. This program will include lectures on atypical forms of T1D, as well as the emerging premise that beta cell dysfunction contributes to progression of this autoimmune disease. A dedicated session for T2D will highlight disease variations and challenge the current dogma associated with genetic and environmental differences between individuals. This conference is being held jointly with Obesity: From Cell to Patient. The program contains joint sessions, workshops, and even a joint Keynote speaker. The joint sessions will highlight the contribution of obesity to T2D pathogenesis, with an emphasis on novel areas of research, including the role of different types and sources of fat, exosome signaling and the role of the microbiome. Overall, this conference strives to raise awareness in the clinical and basic research communities about the need to sub-stratify diabetes to develop better treatment options.
Scholarship Deadline: November 1 2020
Abstract Deadline: December 17 2020
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
AstraZenecaNovo Nordisk A/S
We gratefully acknowledge additional support for this conference from:
ALPCOSable Systems International
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1 R13 DK127701-01
Funding for this conference was made possible (in part) by 1 R13 DK127701-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found